"Mutagenicity Tests" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tests of chemical substances and physical agents for mutagenic potential. They include microbial, insect, mammalian cell, and whole animal tests.
| Descriptor ID |
D009152
|
| MeSH Number(s) |
E05.393.560 E05.940.560
|
| Concept/Terms |
Mutagenicity Tests- Mutagenicity Tests
- Mutagenicity Test
- Toxicity Tests, Genetic
- Mutagen Screening
- Mutagen Screenings
- Screening, Mutagen
- Screenings, Mutagen
- Tests, Genetic Toxicity
- Genetic Toxicity Test
- Toxicity Test, Genetic
- Genetic Toxicity Tests
- Genotoxicity Tests
- Genotoxicity Test
- Test, Genotoxicity
- Tests, Genotoxicity
|
Below are MeSH descriptors whose meaning is more general than "Mutagenicity Tests".
Below are MeSH descriptors whose meaning is more specific than "Mutagenicity Tests".
This graph shows the total number of publications written about "Mutagenicity Tests" by people in this website by year, and whether "Mutagenicity Tests" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Mutagenicity Tests" by people in Profiles.
-
p53-dependent ceramide response to genotoxic stress. J Clin Invest. 1998 Jul 15; 102(2):329-39.
-
Absence of mutagenic effects of continuous and pulsed ultrasound in cultured (AL) human-hamster hybrid cells. Ultrasound Med Biol. 1991; 17(9):921-30.
-
The impact of toxicity on carcinogenicity studies: implications for risk assessment. Carcinogenesis. 1988 Nov; 9(11):2045-52.
-
Exploring relationships between mutagenic and carcinogenic potencies. Mutat Res. 1988 Sep; 196(2):161-75.
-
Sister chromatid exchange in human lymphocytes exposed to ascorbic acid and the cancer chemotherapeutic agent 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea. Teratog Carcinog Mutagen. 1988; 8(6):339-46.